About this FactMed analysis covering adverse side effect reports of AEB071 patients who developed HYPERCALCAEMIA.

FactMed provides MD-approved analysis to help both patients, researchers, and physicians accurately assess the risk profile for more than 20,000 different pharmaceutical products. The below report offers compiled information from Food & Drug Administration and FactMed user submissions. Between January 2004 and October 2012, 1 individuals taking AEB071 reported HYPERCALCAEMIA to the FDA. A total of 37 AEB071 drug adverse event reaction reports were made with the FDA during this time period. Often the FDA only receives reports of the most critical and severe cases; these numbers may therefore underrepresent the complication rate of the medication.

FDA Research Report

Introduction This page is designed to help you determine the relationship, if any, between AEB071 and HYPERCALCAEMIA. In doing so, we compare AEB071 with other drugs that cause HYPERCALCAEMIA, to help you evaluate whether or not AEB071 causes HYPERCALCAEMIA. Likewise, this page shows the most highly-reported side effects of AEB071, so you can see if HYPERCALCAEMIA ranks among AEB071's most well-known side effects.
Summary Statistics
Reports of AEB071 causing HYPERCALCAEMIA: 1
Reports of any side effect of AEB071 : 37
Percentage of AEB071 patients where HYPERCALCAEMIA is a reported side effect: 2.7027%

FDA reports of any drug causing HYPERCALCAEMIA : 4433
Average percentage for all medicated patients where HYPERCALCAEMIA is reported as a complication: 0.0278%

Physician opinion on AEB071 as adverse event culprit:

Overall opinion for all reports of this drug:
Most frequent diagnoses/indications for prescribing AEB071:
RENAL TRANSPLANT ( 34 patients )
( 0 patients )
Drugs with high FDA adverse event association with HYPERCALCAEMIA:

FOSAMAX (1147 patients)
ZOMETA (647 patients)
FORTEO (529 patients)
VIOXX (473 patients)
HEPARIN SODIUM INJECTION (444 patients)
ASPIRIN (425 patients)
REVLIMID (406 patients)
AREDIA (405 patients)
DEXAMETHASONE (374 patients)
LASIX (281 patients)
VELCADE (280 patients)
PREDNISONE (250 patients)
LIPITOR (211 patients)
ALLOPURINOL (211 patients)
OXYCONTIN (207 patients)
PRILOSEC (197 patients)
NEXIUM (196 patients)
HYDROCHLOROTHIAZIDE (195 patients)
LISINOPRIL (192 patients)
ACETAMINOPHEN (179 patients)
LEVAQUIN (169 patients)
DECADRON (167 patients)
NEURONTIN (165 patients)
AMBIEN (164 patients)
CALCIUM CARBONATE (163 patients)
FUROSEMIDE (162 patients)
PROTONIX (162 patients)
NORVASC (157 patients)
OMEPRAZOLE (156 patients)
VITAMIN D (154 patients)
SYNTHROID (150 patients)
COUMADIN (149 patients)
FOLIC ACID (146 patients)
CALCIUM (144 patients)
ZOFRAN (141 patients)
LEVOTHYROXINE SODIUM (137 patients)
THALIDOMIDE (136 patients)
ALBUTEROL (133 patients)
ZOCOR (131 patients)
POTASSIUM CHLORIDE (125 patients)
OXYCODONE HCL (125 patients)
SIMVASTATIN (122 patients)
ATENOLOL (114 patients)
MORPHINE (112 patients)
ALENDRONATE SODIUM (111 patients)
CELEBREX (110 patients)
ATIVAN (110 patients)
LOVENOX (110 patients)
LORAZEPAM (108 patients)
COMPAZINE (108 patients)
VICODIN (105 patients)
ROCALTROL (104 patients)
PREDNISOLONE (102 patients)
PAMIDRONATE DISODIUM (101 patients)
FOSAMAX PLUS D (100 patients)
FENTANYL (100 patients)
TOPROL-XL (99 patients)
LYRICA (98 patients)
PERCOCET (98 patients)
FLUCONAZOLE (96 patients)
METHOTREXATE (96 patients)
ZEMPLAR (95 patients)
THALOMID (95 patients)
AMOXICILLIN (94 patients)
LORTAB (93 patients)
GABAPENTIN (93 patients)
ACYCLOVIR (93 patients)
PREDNISONE TAB (92 patients)
DEXAMETHASONE TAB (91 patients)
IBUPROFEN (90 patients)
PREMARIN (90 patients)
PLAVIX (89 patients)
METOPROLOL TARTRATE (86 patients)
CALCIUM (UNSPECIFIED) (86 patients)
ZANTAC (86 patients)
LEXAPRO (85 patients)
ZOLOFT (84 patients)
NEXAVAR (83 patients)
SEROQUEL (83 patients)
COLACE (81 patients)
CHEMOTHERAPEUTICS NOS (80 patients)
ARANESP (79 patients)
MULTI-VITAMIN (79 patients)
CALCITRIOL (78 patients)
DIOVAN (78 patients)
CYMBALTA (78 patients)
WARFARIN SODIUM (78 patients)
VANCOMYCIN (77 patients)
XANAX (77 patients)
VALIUM (77 patients)
PAXIL (76 patients)
VINCRISTINE (75 patients)
CYCLOPHOSPHAMIDE (75 patients)
PANTOPRAZOLE (73 patients)
FEMARA (73 patients)
REMICADE (73 patients)
PREVACID (72 patients)
PROZAC (72 patients)
DILAUDID (71 patients)
DIAZEPAM (71 patients)
MORPHINE SULFATE (71 patients)
REGLAN (70 patients)
MULTI-VITAMINS (70 patients)
SPIRIVA (70 patients)
DURAGESIC-100 (70 patients)
BACTRIM (69 patients)
ADVAIR DISKUS 100/50 (68 patients)
PEPCID (68 patients)
CISPLATIN (68 patients)
LENALIDOMIDE (67 patients)
MAGNESIUM OXIDE (67 patients)
MS CONTIN (66 patients)
ADRIAMYCIN PFS (66 patients)
ZITHROMAX (66 patients)
ASCORBIC ACID (65 patients)
CALCIUM GLUCONATE (65 patients)
CARBOPLATIN (65 patients)
CHLORHEXIDINE GLUCONATE (64 patients)
NEORAL (64 patients)
SENSIPAR (64 patients)
DIGOXIN (64 patients)
DIFLUCAN (63 patients)
FERROUS SULFATE TAB (63 patients)
AMLODIPINE (62 patients)
CIPROFLOXACIN (62 patients)
CLINDAMYCIN (62 patients)
MAGNESIUM (62 patients)
PROCRIT (61 patients)
ANZEMET (61 patients)
RADIATION THERAPY (61 patients)
FASLODEX (61 patients)
CELEXA (60 patients)
XELODA (60 patients)
CYCLOSPORINE (60 patients)
MIRALAX (59 patients)
CRESTOR (59 patients)
LANTUS (59 patients)
ARIMIDEX (58 patients)
METOCLOPRAMIDE (58 patients)
LITHIUM CARBONATE (57 patients)
RENAGEL (57 patients)
CLONIDINE (56 patients)
EFFEXOR (55 patients)
VITAMIN E (55 patients)
TRAMADOL HCL (55 patients)
SUTENT (55 patients)
KYTRIL (54 patients)
METFORMIN HCL (53 patients)
LOPRESSOR (52 patients)
TAXOTERE (52 patients)
TAXOL (52 patients)
BONIVA (52 patients)
CYTOXAN (52 patients)
FAMOTIDINE (52 patients)
[THERAPY UNSPECIFIED] (52 patients)
MELPHALAN HYDROCHLORIDE (51 patients)
ULTRACET (51 patients)
FLUOROURACIL (51 patients)
ALFACALCIDOL (51 patients)
TEMAZEPAM (51 patients)
SODIUM CHLORIDE (50 patients)
AVELOX (50 patients)
CLARITHROMYCIN (50 patients)
TACROLIMUS (50 patients)
VALTREX (49 patients)
COZAAR (49 patients)
SORAFENIB (48 patients)
CLARITIN (48 patients)
RAMIPRIL (48 patients)
AZITHROMYCIN (48 patients)
CINACALCET HYDROCHLORIDE (48 patients)
TAGAMET (48 patients)
GEMZAR (47 patients)
COREG (47 patients)
HERCEPTIN (47 patients)
THEOPHYLLINE (47 patients)
RANITIDINE (47 patients)
ALLEGRA (47 patients)
METOPROLOL SUCCINATE (46 patients)
METOPROLOL (46 patients)
LANSOPRAZOLE (46 patients)
BUSPAR (46 patients)
PERIDEX (45 patients)
PHENERGAN (45 patients)
SENOKOT (44 patients)
AROMASIN (44 patients)
DARVOCET-N 50 (43 patients)
FLEXERIL (43 patients)
HYDROCODONE (43 patients)
TAMOXIFEN CITRATE (43 patients)
RED BLOOD CELLS (42 patients)
HYDROCODONE BITARTRATE (42 patients)
AFINITOR (42 patients)
ZOLEDRONIC ACID (42 patients)
NYSTATIN (41 patients)
DOXIL (41 patients)
TRAZODONE HYDROCHLORIDE (41 patients)
ZYPREXA (41 patients)
MYCOPHENOLATE MOFETIL (41 patients)
MIACALCIN (41 patients)
NAVELBINE (41 patients)
KLOR-CON (41 patients)
ACTONEL (40 patients)
ONDANSETRON (39 patients)
ENALAPRIL MALEATE (39 patients)
VITAMIN D (UNSPECIFIED) (39 patients)
DOXYCYCLINE (39 patients)
CYCLOBENZAPRINE (39 patients)
TYLENOL (CAPLET) (38 patients)
METHYLPREDNISOLONE (38 patients)
Most common side effects for patients taking AEB071:
VOMITING (6 patients)
NEPHROTIC SYNDROME (5 patients)
PROTEINURIA (5 patients)
ANOREXIA (4 patients)
ASTHENIA (4 patients)
DIZZINESS (4 patients)
FUNGAL OESOPHAGITIS (4 patients)
GASTRIC ULCER HAEMORRHAGE (4 patients)
GASTRITIS (4 patients)
KIDNEY TRANSPLANT REJECTION (4 patients)
NAUSEA (4 patients)
REFLUX OESOPHAGITIS (4 patients)
DIARRHOEA (3 patients)
DRUG INEFFECTIVE (3 patients)
ELECTROCARDIOGRAM QT PROLONGED (3 patients)
FEELING ABNORMAL (3 patients)
GLOMERULONEPHRITIS (3 patients)
HAEMOGLOBIN DECREASED (3 patients)
INCISION SITE PAIN (3 patients)
INSOMNIA (3 patients)
POST PROCEDURAL HAEMATOMA (3 patients)
PULMONARY EMBOLISM (3 patients)
ANURIA (2 patients)
BLOOD ALBUMIN DECREASED (2 patients)
CONSTIPATION (2 patients)
COUGH (2 patients)
DRUG INTERACTION (2 patients)
EAR PAIN (2 patients)
FATIGUE (2 patients)
FEBRILE NEUTROPENIA (2 patients)
GASTROENTERITIS (2 patients)
GASTROINTESTINAL INFECTION (2 patients)
HIATUS HERNIA (2 patients)
HYPOTENSION (2 patients)
IMMUNOSUPPRESSANT DRUG LEVEL INCREASED (2 patients)
INFECTION (2 patients)
NASAL CONGESTION (2 patients)
PHARYNGOLARYNGEAL PAIN (2 patients)
PNEUMOCOCCAL SEPSIS (2 patients)
PNEUMONIA (2 patients)
POST PROCEDURAL HAEMORRHAGE (2 patients)
PSEUDOMONAS INFECTION (2 patients)
PYREXIA (2 patients)
RENAL IMPAIRMENT (2 patients)
UPPER-AIRWAY COUGH SYNDROME (2 patients)
URINARY TRACT INFECTION (2 patients)
URINOMA (2 patients)
ABDOMINAL PAIN (1 patients)
AGEUSIA (1 patients)
ANAEMIA (1 patients)
BACTERIAL INFECTION (1 patients)
BLADDER CATHETER REMOVAL (1 patients)
BLADDER CATHETERISATION (1 patients)
BLADDER OPERATION (1 patients)
BLOOD POTASSIUM DECREASED (1 patients)
BLOOD POTASSIUM INCREASED (1 patients)
COAGULOPATHY (1 patients)
CYSTOSTOMY (1 patients)
DEATH (1 patients)
DECREASED APPETITE (1 patients)
DEHYDRATION (1 patients)
DYSLIPIDAEMIA (1 patients)
DYSPEPSIA (1 patients)
DYSPNOEA (1 patients)
ELECTROCARDIOGRAM ABNORMAL (1 patients)
FALL (1 patients)
GASTROINTESTINAL HAEMORRHAGE (1 patients)
HAEMORRHOIDS (1 patients)
HEPATIC FUNCTION ABNORMAL (1 patients)
HYPERCALCAEMIA (1 patients)
HYPERGLYCAEMIA (1 patients)
HYPOXIA (1 patients)
INFLAMMATION (1 patients)
INTERNATIONAL NORMALISED RATIO DECREASED (1 patients)
KIDNEY FIBROSIS (1 patients)
LYMPHATIC FISTULA (1 patients)
LYMPHOCELE (1 patients)
OCCULT BLOOD POSITIVE (1 patients)
OEDEMA (1 patients)
OEDEMA PERIPHERAL (1 patients)
PROTEIN TOTAL DECREASED (1 patients)
PROTHROMBIN TIME PROLONGED (1 patients)
PYELONEPHRITIS (1 patients)
RECTAL HAEMORRHAGE (1 patients)
RENAL ATROPHY (1 patients)
RENAL FAILURE ACUTE (1 patients)
RENAL TUBULAR NECROSIS (1 patients)
SCROTAL OEDEMA (1 patients)
SEPSIS (1 patients)
SEPTIC SHOCK (1 patients)
SHOCK HAEMORRHAGIC (1 patients)
SKIN LESION (1 patients)
SURGERY (1 patients)
TACHYCARDIA (1 patients)
TOXICITY TO VARIOUS AGENTS (1 patients)
URETHRAL DILATATION (1 patients)
URETHRAL OPERATION (1 patients)
URETHRAL STENOSIS (1 patients)
URINARY TRACT INFECTION PSEUDOMONAL (1 patients)
UROSTOMY (1 patients)
VESICOURETERAL REFLUX SURGERY (1 patients)
WEIGHT DECREASED (1 patients)
WEIGHT INCREASED (1 patients)

In addition to reviewing our up-to-date FDA research, users may interact with the FactMed community - currently one million members and growing! FactMed online research and discussions are read by patients, scientists, physicians, and other interested health care parties. Post follow up Questions to learn from our diverse readership. Likewise, patients who have experienced unwanted effects are encouraged to share their Concerns to help educate and inform our members.


Recent FactMed Activity for AEB071


Issue Description / Topic Timestamp

My Patient Resources

Get your questions answered! Over one million patients, researchers, and health care providers have visited FactMed. If you have a question about HYPERCALCAEMIA and AEB071, post it here. You may receive a response from a fellow patient - or a leading expert in the field.
Your Question:

Share your experience: Over one million patients, researchers, and health care providers have visited FactMed. If you have a noteworthy experience as a patient taking AEB071, post it here. Your story could help a fellow patient - or provide insight to a leading expert in the field.
Your Experience or Concern:

Telemedicine Expert Consults FactMed newest feature allows patients to consult - via realtime videoconferencing - experts in AEB071. This premium feature connects patients to experts, regardless of geography. FactMed experts charge reasonable rates that may be reimbursable by your insurance as a second-opinion.
We are currently accepting registration for AEB071 experts. If you are a healthcare provider experienced in prescribing AEB071, please register here.
giCould not connect: